Kairos Pharma, LTD.·4

Nov 25, 6:03 AM ET

Samuelson Doug 4

4 · Kairos Pharma, LTD. · Filed Nov 25, 2024

Insider Transaction Report

Form 4
Period: 2024-11-22
Samuelson Doug
Chief Financial Officer
Transactions
  • Purchase

    COMMON STOCK

    2024-11-22$1.50/sh+2,500$3,75060,796 total

Documents

1 file
  • 4
    ownership.xmlPrimary